Clinical Trial Update: A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 long-term safety study of methylphenidate HCl tablets in adults with Attention Deficit Hyperactivity Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate hydrochloride tablets (Methylphenidate hydrochloride)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED